SPRO - Spero Therapeutics - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

SPRO is currently covered by 4 analysts with an average price target of $10.14. This is a potential upside of $8.39 (479.43%) from yesterday's end of day stock price of $1.75.

Spero Therapeutics's activity chart (see below) currently has 12 price targets and 22 ratings on display. The stock rating distribution of SPRO is 85.71% BUY and 14.29% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 25% with an average time for these price targets to be met of 40.5 days.

Highest price target for SPRO is $7, Lowest price target is $7, average price target is $10.14.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 18-Mar-2024.

Best performing analysts who are covering SPRO - Spero Therapeutics:

Kevin Degeeter Esther Hong Raghuram Selvaraju Louise Chen Josh Schimmer Ritu Baral

Currently out of the existing stock ratings of SPRO, 12 are a BUY (85.71%), 2 are a HOLD (14.29%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

7

$5.25 (300.00%)

7

10 days ago

0/12 (0%)

$5.27 (304.62%)

Buy

8

$6.25 (357.14%)

2

1 years 6 months 5 days ago

1/2 (50%)

$6.03 (306.09%)

2

Hold

47

1 years 10 months 8 days ago

0/1 (0%)

$28.64 (155.99%)

Buy

5

$3.25 (185.71%)

27

1 years 10 months 11 days ago

0/3 (0%)

$3.35 (203.03%)

Buy

21

2 years 5 months 27 days ago

2/2 (100%)

$7.02 (60.23%)

241

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is SPRO (Spero Therapeutics) average time for price targets to be met?

On average it took 40.5 days on average for the stock forecasts to be realized with a an average price target met ratio 25

Which analyst has the current highest performing score on SPRO (Spero Therapeutics) with a proven track record?

KEVIN DEGEETER

Which analyst has the current lower performing score on SPRO (Spero Therapeutics) with a proven track record?

RITU BARAL

Which analyst has the most public recommendations on SPRO (Spero Therapeutics)?

Kevin Degeeter has 7 price targets and 6 ratings on SPRO

Which analyst is the currently most bullish on SPRO (Spero Therapeutics)?

Josh Schimmer with highest potential upside - $6.25

Which analyst is the currently most reserved on SPRO (Spero Therapeutics)?

Esther Hong with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?